B Archana

Rani Therapeutics (United States)

Papers

1

Total Citations

2

H-Index

1

About

Dr. B. Archana is a leading researcher in the field of oral drug delivery systems, with a particular focus on the pharmacokinetics and pharmacodynamics of peptide and protein therapeutics. Her most cited work, "SAT236 Pharmacokinetics (PK) And Pharmacodynamics (PD) Of The Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered Via An Orally Administered Robotic Pill (RT-102)" (2023, 2 citations), represents a groundbreaking contribution to the development of non-invasive delivery methods for biologics. This study demonstrates the feasibility of using a robotic pill to achieve systemic absorption of teriparatide, a parathyroid hormone analog used in osteoporosis treatment, thereby eliminating the need for daily injections. Dr. Archana’s research addresses a critical challenge in drug delivery—enhancing patient compliance for chronic therapies. Her work on the RT-102 platform has significant implications for the oral administration of other peptide drugs, potentially transforming treatment paradigms. With a growing citation impact, Dr. Archana is recognized for her innovative approach to merging robotics with pharmaceutical science, and her contributions are paving the way for more patient-friendly therapeutic options.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
SAT236 Pharmacokinetics (PK) And Pharmacodynamics (PD) Of The Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered Via An Orally Administered Robotic Pill (RT-102)
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Rani Therapeutics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago